Micrus picks up FAST blood clot technology
This article was originally published in Clinica
Executive Summary
In a move to expand its endovascular product offerings, Micrus Endovascular has acquired development and commercialisation rights to a blood clot removal technology developed by fellow Californian company Genesis Medical Interventional.